Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethical issues in drug selection for schizophrenia

J J Jeffries1

  • 1Department of Psychiatry and Pharmacy, Clarke Institute of Psychiatry, Toronto, Ontario.

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|September 1, 1993
PubMed
Summary

New antipsychotic medications offer potential benefits for schizophrenia treatment but require realistic assessment of their efficacy and side effects. Clinicians must balance treatment complexities with fostering patient insight and collaboration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delayed cognitive decline following cranial irradiation.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·1999
Same author

Psychosis secondary to long-term levamisole therapy.

The Annals of pharmacotherapy·1998
Same author

Re: Rapid stabilization at home.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·1997
Same author

Desmopressin for enuresis in psychiatric patients.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·1996
Same author

Re: Treatment of SAD.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·1996
Same author

Loxapine: an enigma.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·1996

Area of Science:

  • Pharmacology
  • Psychiatry
  • Medical Ethics

Background:

  • Neuroleptics, introduced over 40 years ago, revolutionized schizophrenia treatment but are associated with significant side effects.
  • The development of new atypical antipsychotics, like clozapine, necessitates a realistic evaluation beyond viewing them as cures.
  • Schizophrenia treatment involves complex legal and ethical considerations regarding informed consent due to potential drug toxicities.

Purpose of the Study:

  • To critically assess the advantages of new atypical neuroleptics.
  • To evaluate their impact on positive and negative symptoms of schizophrenia.
  • To analyze potential adverse effects and cost-benefit ratios.

Main Methods:

  • Critical evaluation of existing literature on atypical antipsychotics.
Keywords:
Mental Health Therapies

Related Experiment Videos

  • Analysis of effects on positive and negative symptomatology.
  • Assessment of adverse effects and cost-benefit.

    • Main Results:

    • New atypical neuroleptics require realistic appraisal of their benefits and risks.
    • Evaluation should encompass efficacy, side effects, and economic factors.
    • Challenges in obtaining informed consent persist due to drug toxicities.

    Conclusions:

    • Clinicians should realistically assess new antipsychotics, considering both benefits and drawbacks.
    • Fostering patient insight and a collaborative approach is crucial for managing schizophrenia.
    • Despite treatment challenges, a patient-centered strategy is vital for coping with schizophrenia.